112 related articles for article (PubMed ID: 11936353)
1. Role of glycopeptides in the treatment of septic complications after cardiac surgery.
Bourgoin A; Léone M; Martin C
J Chemother; 2001 Nov; 13 Spec No 1(1):112-8. PubMed ID: 11936353
[TBL] [Abstract][Full Text] [Related]
2. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
Mohan SS; McDermott BP; Cunha BA
Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
[TBL] [Abstract][Full Text] [Related]
3. [Aminoglycosides in the treatment of infectious endocarditis].
Malinverni R
Schweiz Med Wochenschr Suppl; 1996; 76():14S-20S. PubMed ID: 8677414
[TBL] [Abstract][Full Text] [Related]
4. Aminoglycoside resistant enterococcal endocarditis.
Eliopoulos GM
Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
[TBL] [Abstract][Full Text] [Related]
5. Rifampin treatment of prosthetic valve endocarditis due to Staphylococcus epidermidis.
Karchmer AW; Archer GL; Dismukes WE
Rev Infect Dis; 1983; 5 Suppl 3():S543-8. PubMed ID: 6556711
[TBL] [Abstract][Full Text] [Related]
6. Prosthetic valve endocarditis caused by Staphylococcus epidermidis. Development of rifampin resistance during vancomycin and rifampin therapy.
Chamovitz B; Bryant RE; Gilbert DN; Hartstein AI
JAMA; 1985 May; 253(19):2867-8. PubMed ID: 3989962
[TBL] [Abstract][Full Text] [Related]
7. Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy.
Karchmer AW; Archer GL; Dismukes WE
Ann Intern Med; 1983 Apr; 98(4):447-55. PubMed ID: 6838067
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin.
Ahmad NM; Rojtman AD
Ann Pharmacother; 2010 May; 44(5):918-21. PubMed ID: 20354160
[TBL] [Abstract][Full Text] [Related]
9. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].
Pişkin N; Akduman D; Aydemir H; Celebi G; Oztoprak N; Aktaş E
Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897
[TBL] [Abstract][Full Text] [Related]
10. [Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica].
Gudiol F; Aguado JM; Pascual A; Pujol M; Almirante B; Miró JM; Cercenado E; Domínguez Mde L; Soriano A; Rodríguez-Baño J; Vallés J; Palomar M; Tornos P; Bouza E;
Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):105-15. PubMed ID: 19254641
[TBL] [Abstract][Full Text] [Related]
11. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcal endocarditis. Laboratory and clinical basis for antibiotic therapy.
Karchmer AW
Am J Med; 1985 Jun; 78(6B):116-27. PubMed ID: 3893113
[TBL] [Abstract][Full Text] [Related]
13. The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.
McConeghy KW; Bleasdale SC; Rodvold KA
Clin Infect Dis; 2013 Dec; 57(12):1760-5. PubMed ID: 23985343
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with daptomycin: bacteraemia and endocarditis.
Levine DP
J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii35-39. PubMed ID: 18829724
[TBL] [Abstract][Full Text] [Related]
15. Prosthetic valve endocarditis from Granulicatella adiacens (nutritionally variant streptococci).
Jeng A; Chen J; Katsivas T
J Infect; 2005 Oct; 51(3):e125-9. PubMed ID: 16230190
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus bacteremia and endocarditis.
Chang FY
J Microbiol Immunol Infect; 2000 Jun; 33(2):63-8. PubMed ID: 10917874
[TBL] [Abstract][Full Text] [Related]
17. [A case report of active aortic prosthetic valve endocarditis due to methicillin-resistant Staphylococcus epidermidis].
Asakura T; Aoki K; Tadokoro M; Tanaka H; Furuta S
Nihon Kyobu Geka Gakkai Zasshi; 1996 Aug; 44(8):1185-92. PubMed ID: 8828382
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
Madrigal AG; Basuino L; Chambers HF
Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
[TBL] [Abstract][Full Text] [Related]
19. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
Cosgrove SE; Vigliani GA; Fowler VG; Abrutyn E; Corey GR; Levine DP; Rupp ME; Chambers HF; Karchmer AW; Boucher HW
Clin Infect Dis; 2009 Mar; 48(6):713-21. PubMed ID: 19207079
[TBL] [Abstract][Full Text] [Related]
20. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
Wareham DW; Abbas H; Karcher AM; Das SS
J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]